Wakamoto Pharmaceutical News and Activities

Wakamoto Pharmaceutical is a company listed under the stock ticker 4512 (JP).

View the org chart displaying its 14 main executives

Most searched biographies at Wakamoto Pharmaceutical

• Arata Igarashi, President and Representative Director
• Haruhisa Hirata, Director
• Ikuro Kuwahara, Outside Director

Create your alert
to follow the executive moves at Wakamoto Pharmaceutical.

Wakamoto Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Wakamoto Pharmaceutical

• ニュース一覧｜わかもと製薬
• ニュース一覧｜わかもと製薬
• ニュース一覧｜わかもと製薬

Social media about Wakamoto Pharmaceutical

• Wakamoto Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Wakamoto Pharmaceutical on LinkedIn, X (Twitter) & YouTube